National Center for Advancing Translational Sciences – Small Business
Program Funding
Annual program obligations reported to SAM.gov.
Program Objective
The National Center for Advancing Translational Sciences' (NCATS') mission is to turn research observations into health solutions through translational science. We work to develop or enhance the development, testing, and implementation of diagnostics and therapeutics for a wide range of diseases and conditions. Key approaches include understanding what’s similar across diseases to spur multiple treatments at a time, developing models that better predict a person’s reaction to treatment, enhancing clinical trials so results more accurately reflect the patient population, and leveraging real-world data and data science approaches to address public health needs. Facilitating these approaches are our robust partnerships with other government agencies, including other NIH institutes, centers, and offices; industry; academia; nonprofit organizations; and patients, patient advocates, and other communities. NCATS' vision is to bring more treatments for all people more quickly.
Eligibility
Eligible Applicants
- Other
How to Apply
Award Procedure
The initial review of applications from eligible institutions is conducted by committees comprised of authorities in various fields of biomedical research and science education, as appropriate. Each application is given a peer evaluation for merit. Recommendations for award are forwarded to the NCATS Advisory Council for the second level of review and recommendation for award.
Decision Timeline
- Approval: > 180 Days
- Renewal interval: > 180 Days
- Appeal: From 15 to 30 days
Program details & compliance
Description
The National Center for Advancing Translational Sciences (NCATS) Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs help small businesses develop and commercialize new translational technologies.
Mission Categories
Primary: Research and Development
Other categories:
General Health and Medical
Use of Funds
Allowed Uses
NCATS is all about getting more treatments to all patients more quickly. A novel drug, device or intervention can take 14 years and $2 billion to develop, with a failure rate exceeding 95%. NCATS is directly addressing this problem by discovering new technologies and other approaches that could greatly accelerate the process of developing and deploying solutions that can be used by all translational researchers. Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs utilize the grant and cooperative agreement mechanisms to help eligible US based small businesses develop new translational technologies that can eventually be commercialized to provide health solutions.
Required Documentation
The required credentials of the applicant are described in the relevant Notice of Funding Opportunity.
Reporting & Compliance
Applicable 2 CFR 200 Subparts
- Subpart B — General Provisions
- Subpart C — Pre-Federal Award Requirements
- Subpart D — Post-Federal Award Requirements
- Subpart E — Cost Principles
- Subpart F — Audit Requirements